The purpose of this clinical trial is to evaluate an investigational drug for the potential treatment of MAC lung infections and evaluate symptomatic improvement, including effects on respiratory discomfort and fatigue.
This study (also called a clinical trial) will include adults from around the world with MAC lung infections. Your participation in the study could help increase the knowledge and understanding of MAC lung infections to potentially benefit the broader MAC community.
By providing your email and phone number, you are authorizing Science 37 to contact you about this and other studies, and you agree to the Privacy Policy.
We may send you a text message regarding these studies. Message and data rates may apply.
What Can I do Next
Answer the prescreen questionnaire on this website.
We have an awesome team of doctors, researchers, and patient experience coordinators who are eager to help guide you through the research process.
Frequently Asked Questions
855-382-3060
MAC_infection@Science37.com
Do you know someone interested in helping with our research?
Share this study:
Frequently Asked Questions (FAQ)
How do I get started?
Click here to begin the prescreening survey to see if you may qualify.
Will I receive compensation?
You will not receive any payment for taking part in the study. You may receive:
Study-related treatment at no cost Travel support for clinic visits
Where is the study conducted?
The study will be conducted in various regions across the world.
What about my current medications?
Once you have given your consent, the study doctor will discuss this with you and determine if you are eligible and able to continue using your current medications.
Do I need health insurance?
Health insurance is not required to participate in the study.
Can I leave the study at any time?
You are free to withdraw from the study at any time without giving a reason and without your medical care or rights being affected.
What is the importance of clinical trials for MAC?
Not all MAC patients respond to currently available treatments. Therefore, there is a need to develop and find potential new treatments for people with MAC lung infection through clinical studies.
How long will the study last?
Enrolled participants will be in the study for up to 18 months and will visit the study site regularly.
What is a Phase 3 clinical study?
When new drugs are being studied as possible treatments for patients with a disease, they are tested in stages or “phases.” A Phase 3 clinical study is one of the later phases of testing in patients.
